Thane Wettig
Overview
Thane Wettig received an average of $4M in total compensation, including $387K in salary, at FibroGen between 2020 and 2021.
Source: SEC filings on April 28, 2022 and April 13, 2021.
Related executives
We found ten more executives who work or worked at FibroGen.
Enrique Conterno
FibroGen
Chief Executive Officer
Christine Chung
FibroGen
Senior Vice President, China Operations
Mark Eisner
FibroGen
Chief Medical Officer
Pat Cotroneo
FibroGen
Chief Financial Officer
Elias Kouchakji
FibroGen
Senior Vice President, Clinical Development, Drug Safety, and Pharmacovigilance
Juan Graham
FibroGen
Chief Financial Officer
K Yu
FibroGen
Chief Medical Officer
James Schoeneck
FibroGen